Piaopiao Lian

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

From plasma proteomics Mendelian randomization to neuropathological validation: The potential role of CTSH-GRN-TMEM106B and TREM2-IL-34 networks of microglia in Alzheimer's disease.

From plasma proteomics Mendelian randomization to neuropathological validation: The potential role of CTSH-GRN-TMEM106B and TREM2-IL-34 networks of microglia in Alzheimer's disease.

Journal: European journal of pharmacology

Published: June 19, 2025

Disruption of axonal transport in Parkinson's disease: the role of pathological α-Syn and AMPK/p38 MAPK signaling.

Disruption of axonal transport in Parkinson's disease: the role of pathological α-Syn and AMPK/p38 MAPK signaling.

Journal: NPJ Parkinson's disease

Published: November 21, 2024

Biomarkers in Alzheimer's disease: Emerging trends and clinical implications.

Biomarkers in Alzheimer's disease: Emerging trends and clinical implications.

Journal: Chinese medical journal

Published: August 31, 2024

Alpha-synuclein Fibrils Inhibit Activation of the BDNF/ERK Signaling Loop in the mPFC to Induce Parkinson's Disease-like Alterations with Depression.

Alpha-synuclein Fibrils Inhibit Activation of the BDNF/ERK Signaling Loop in the mPFC to Induce Parkinson's Disease-like Alterations with Depression.

Journal: Neuroscience bulletin

Published: July 19, 2024

Irisin inhibits microglial senescence via TFAM-mediated mitochondrial metabolism in a mouse model of tauopathy.

Irisin inhibits microglial senescence via TFAM-mediated mitochondrial metabolism in a mouse model of tauopathy.

Journal: Immunity & ageing : I & A

Published: March 19, 2024

Analysis and experimental validation of necroptosis-related molecular classification, immune signature and feature genes in Alzheimer's disease.

Analysis and experimental validation of necroptosis-related molecular classification, immune signature and feature genes in Alzheimer's disease.

Journal: Apoptosis : an international journal on programmed cell death

Published: February 04, 2024

AMPK-mediated autophagy pathway activation promotes ΔFosB degradation to improve levodopa-induced dyskinesia.

AMPK-mediated autophagy pathway activation promotes ΔFosB degradation to improve levodopa-induced dyskinesia.

Journal: Cellular signalling

Published: January 22, 2024

Identification and experimental validation of m7G-related molecular subtypes, immune signature, and feature genes in Alzheimer's disease.

Identification and experimental validation of m7G-related molecular subtypes, immune signature, and feature genes in Alzheimer's disease.

Journal: Heliyon

Published: September 15, 2023

Identification of metabolism-related subtypes and feature genes in Alzheimer's disease.

Identification of metabolism-related subtypes and feature genes in Alzheimer's disease.

Journal: Journal of translational medicine

Published: May 19, 2023

Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review.

Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review.

Journal: Frontiers in molecular neuroscience

Published: February 23, 2023

ONO-2506 Can Delay Levodopa-induced Dyskinesia in the Early Stage.

ONO-2506 Can Delay Levodopa-induced Dyskinesia in the Early Stage.

Journal: Neuroscience

Published: November 01, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026